Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/209206
Title: Can Oncologists Prompt Patient Prognostic Awareness to Enhance Decision-Making? Data From the NEOetic Study
Author: Carmona Bayonas, Alberto
Rodríguez-González, Adán
García-García, Teresa
Velasco-Durántez, Verónica
Hernández, Raquel
Cruz-Castellanos, Patricia
Fernández Montes, Ana
Castillo-Trujillo, Oscar
Ballester Pastor, Inmaculada
Rogado, Jacobo
Calderón Garrido, Caterina
Jiménez Fonseca, Paula
Keywords: Oncologia
Pronòstic mèdic
Presa de decisions
Malalts de càncer
Aspectes psicològics
Relacions metge-pacient
Qualitat de vida
Oncology
Prognosis
Decision making
Cancer patients
Psychological aspects
Physician-patient relationships
Quality of life
Issue Date: 26-Apr-2023
Publisher: AlphaMed Press
Abstract: Introduction: Anti-neoplastic therapy improves the prognosis for advanced cancer, albeit it is not curative. An ethical dilemma that often arises during patients’ first appointment with the oncologist is to give them only the prognostic information they can tolerate, even at the cost of compromising preference-based decision-making, versus giving them full information to force prompt prognostic awareness, at the risk of causing psychological harm. Methods: We recruited 550 participants with advanced cancer. After the appointment, patients and clinicians completed several questionnaires about preferences, expectations, prognostic awareness, hope, psychological symptoms, and other treatment-related aspects. The aim was to characterize the prevalence, explanatory factors, and consequences of inaccurate prognostic awareness and interest in therapy. Results: Inaccurate prognostic awareness affected 74%, conditioned by the administration of vague information without alluding to death (odds ratio [OR] 2.54; 95% CI, 1.47-4.37, adjusted P = .006). A full 68% agreed to low-efficacy therapies. Ethical and psychological factors oriented firstline decision-making, in a trade-off in which some lose quality of life and mood, for others to gain autonomy. Imprecise prognostic awareness was associated with greater interest in low-efficacy treatments (OR 2.27; 95% CI, 1.31-3.84; adjusted P = .017), whereas realistic understanding increased anxiety (OR 1.63; 95% CI, 1.01-2.65; adjusted P = 0.038), depression (OR 1.96; 95% CI, 1.23-3.11; adjusted P = .020), and diminished quality of life (OR 0.47; 95% CI, 0.29-0.75; adjusted P = .011). Conclusion: In the age of immunotherapy and targeted therapies, many appear not to understand that antineoplastic therapy is not curative. Within the mix of inputs that comprise inaccurate prognostic awareness, many psychosocial factors are as relevant as the physicians’ disclosure of information. Thus, the desire for better decision-making can actually harm the patient.
Note: Reproducció del document publicat a: https://doi.org/10.1093/oncolo/oyad100
It is part of: The Oncologist, 2023, vol. 28, num.11, p. 986-995
URI: https://hdl.handle.net/2445/209206
Related resource: https://doi.org/10.1093/oncolo/oyad100
ISSN: 1083-7159
Appears in Collections:Articles publicats en revistes (Psicologia Clínica i Psicobiologia)

Files in This Item:
File Description SizeFormat 
260504.pdf1.14 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons